Minireviews
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Ophthalmol. Nov 12, 2014; 4(4): 160-165
Published online Nov 12, 2014. doi: 10.5318/wjo.v4.i4.160
Donor cornea quality used for penetrating keratoplasty vs deep anterior lamellar keratoplasty
Sepehr Feizi
Sepehr Feizi, Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran 16666, Iran
Author contributions: Feizi S solely contributed to this paper with respect to (1) conception and design; (2) drafting the article and revising it critically; and (3) final approval of the version to be published.
Supported by The Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence to: Sepehr Feizi, MD, MSc, Assistant Professor of Ophthalmology, Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Boostan 9 St., Pasdaran Ave., Tehran 16666, Iran. sepehrfeizi@yahoo.com
Telephone: +98-21-22584733 Fax: +98-21-22562138
Received: April 26, 2014
Revised: July 18, 2014
Accepted: September 4, 2014
Published online: November 12, 2014
Core Tip

Core tip: Deep anterior lamellar keratoplasty (DALK) is recently used for treating corneal diseases not affecting the corneal endothelium. This makes it possible to use donor tissue with poor endothelium. Furthermore, DALK allows acellular corneal tissue to be used and long-term preservation techniques are being considered as a method for donor storage. The recent alterations may require eye banks and corneal surgeons to reassess their selection criteria to ensure donor grafts which are inappropriate for penetrating keratoplasty because of low endothelial cell count can be safely used for DALK.